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a b s t r a c t
We present the case of a 74-year-old man originally scheduled for planned surgical aortic valve
replacement due to suspected infective endocarditis on a severely stenotic valve. Blood
cultures revealed Enterococcus faecalis and Klebsiella pneumoniae (ESBL+). Logistic Euroscore
was 9.11% and STS for isolated AV replacement (AVR) showed mortality risk 2.539% and
21.784% morbidity or mortality risk, respectively. AVR procedure was performed with mini-
thoracotomy approach, ESP 100-21 mm SJM prosthesis was implanted. On the 10th day
following the procedure fever spikes with CRP and WBC elevation reoccurred and further
course of the disease with all its capabilities was rather unfortunate and ended up fatally.
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.Introduction
We present the case of a 74-year-old man originally scheduled
for planned surgical aortic valve replacement due to suspected
infective endocarditis on a severely stenotic valve.
Infective endocarditis remains a challenge both to diagnose
and to treat. Positive results depend on a rapid diagnosis,
accurate stratiﬁcation of the risk and a meticulous follow-up.
Our patient was originally a rather typical case of infective
endocarditis planned for treatment with valve replacement as
recommended in the European Society of Cardiology 2009
Guidelines. Unfortunately further course of the disease with
all its capabilities was rather unfortunate and ended up fatally.* Corresponding author at  : Wo łoska Str. 137, 02-507 Warsaw, Poland.      
E-mail address: s.iadariusz@upcpoczta.pl (D.A. Kosior).
http://dx.doi.org/10.1016/j.crvasa.2014.08.001
0010-8650/# 2014 The Czech Society of Cardiology. Published by ElseCase report 
A 74-year-old white male (with history of hypertension and
previously diagnosed severe aortic stenosis) scheduled for
planned surgical valve replacement was admitted to the
Department of Noninvasive Cardiology and Hypertension due
to suspected infective endocarditis. Patient presented with
fever (maximum of 38.5 8C), general fatigue, weight loss of 3 kg
(in 3 weeks), lack of appetite, increasing dyspnea (New York
Heart Association Class III), signs of upper respiratory tract
infection. During physical examination at admission addi-
tionally apart from fever (38 8C), tachycardia (112 heart beats
per minute), signs of increased adrenergic activity, i.e.,Tel.: +(22) 508 16 70/71; fax: +(22) 508 16 80.         
vier Urban & Partner Sp. z o.o. All rights reserved.. 
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coronary angiography performed a month before admission
showed no signs of coronary artery disease. Transesophageal
echocardiography (TEE) revealed vegetation on left and right
aortic cusps (left ventricle ejection fraction (LVEF) 60%, peak/
mean gradient 94/45 mmHg, aortic valve area (AVA) 0.97 cm2,
no aortic regurgitation (AI)). Laboratory data at admission
revealed: white blood count (WBC) 16.69 thousands/mL (norm
4.5–10.0 thousands/mL), neutrophiles (NEU) 14.07 thousands/
mL (norm 1.90–7.00 thousands/mL), % of neutrophiles 84.3%
(norm 40.0–68.00%), ﬁbrinogen 196 mg/dl (norm 200–393 mg/dl),
C-reactive protein (CRP) was not performed. Blood cultures
revealed Enterococcus faecalis and Klebsiella pneumoniae
(ESBL+). First 6 bottles after incubation detailed analysis
showed: bottle (1) – Enterococcus faecalis ESBL (), HLAR (),
VRE () (ampicillin-sensitive (S), gentamicin-resistant (R),
streptomycin-R, vancomycin-S, teicoplanin-S), bottles (2)–(4)
– were exact same as bottle (1), bottles (5) and (6) were negative.
Second 6 bottles after incubation detailed analysis showed:
bottles (1) and (2) exact as results mentioned above with
Enterococcus feacalis, bottles (3) and (4) were negative and
bottles (5) and (6) – Klebsiella pneumaoniae ESBL(+), sensitive
only for imipenem, meropenem and ertapenem. Previously
implemented empiric antibiotics (cefazoline 1 g bid) were
modiﬁed (after detailed analysis with Head of the Microbiology
Department ciproﬂoxacin 200 mg bid with amicacin 1 g bid wereFig. 1 – (A) Vegetation attached to the mitral valve leaflet (TEE), (
annulus disembowelment (TEE, 3D reconstruction), (D) multiple 
reconstruction).introduced for 7 days) with no signiﬁcant medical improvement.
Again after detailed analysis with Head of the Microbiology
Department ciproﬂoxacin was stopped, amicacin 1 g bid was
continued and amixicilin with clavulonic acid 1.2 g tid and
metronidazol 500 mg bid were added, this regimen was
continued for 15 days. During following days patient stabilized,
inﬂammatory parameters dropped (including WBC, CRP and
NEU). Logistic Euroscore was 9.11% and STS for isolated AV
replacement (AVR) showed mortality risk 2.539% and 21.784%
morbidity or mortality risk, respectively. AVR procedure was
performed with mini-thoracotomy approach, ESP 100-21 mm
SJM prosthesis was implanted. On the 10th day following the
procedure fever spikes with CRP and WBC elevation reoc-
curred. Blood culture revealed the same bacterial species
(Enterococcus faecalis and Klebsiella pneumoniae ESBL(+)).
Subsequent modiﬁcation of pharmacotherapy was applied,
again after detailed analysis with Head of the Microbiology
Department amicacin 1 g bid and metronidazol 500 mg bid
were stopped, amixicilin with clavulonic acid 1.2 g tid was
continued and vancomycine 1 g bid was added – for 4 days
without signiﬁcant inﬂuence on the disease. After 4 days
another change was made, vancomycine 1 g bid was contin-
ued and meronem 2 g bid. Following transthoracic echocar-
diographs (TTE) and TEE showed progressive signs of infective
endocarditis on the replaced valve with extensive vegetations
(Fig. 1A), abscesses (Fig. 1B), with dysfunction of prosthesisB) possible periannular multiple abscesses (TTE), (C) aortic
infective endocarditis complications in one patient (TEE, 3D
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(Fig. 1C)), and signs of severe perivalvular leak. Within couple
of days, despite complex and intense antibiotics therapy,
vegetations within right atrium and mitro-aortic continuum
infective inﬁltrations were detected. Due to medical condition
surgical aortic and mitral valve replacement (SJM mechanical
valves) with extraction of visible vegetations were performed
with acceptable results of the procedure. Unfortunately,
despite unusual actions applied, patient died on the third
day following surgery. Presented case shows unfortunate
outcome of infective endocarditis (primarily of the native AV)
with the progressive nature of the infectious process (despite
optimal pharmacological therapy and heroic surgical inter-
ventions), which resulted in almost all the complications
mentioned in the literature in a single patient (Fig. 1D).
Discussion
Surgical treatment of infective endocarditis due to severe
complications is performed in about 50% of patients [1].
Surgical treatment in the acute phase of the disease is
considered in order to avoid progressing heart failure,
irreversible structural damage due to severe infection and in
order to avoid systemic emboli [2]. On the other hand, surgical
treatment brings signiﬁcant risk. In some cases Guidelines
recommend immediate surgery (in less than 24 h) or urgent
surgery (within couple of days) regardless of the length of the
antibiotic treatment. In other cases surgery can be slightly
delayed. As mentioned three main indications for surgery are
heart failure, uncontrolled infection and avoidance of the
systemic emboli. Taking all that under consideration decision
in our case to proceed with the planned operation seemed
right and balanced.
Unfortunately, couple of days after the ﬁrst operation
severe infection reoccurred, blood culture revealed the same
bacterial species and as mentioned subsequent modiﬁcation
of pharmacotherapy did not have signiﬁcant inﬂuence on the
disease course and patient rapidly deteriorated. What is more
we had, at that time, an infective endocarditis not on a native,
but on a prosthetic valve. There are several risk factors
connected with worse prognosis in infective endocarditis and
endocarditis on a prosthetic valve is one of them. Among
others we have:
 periannular complications (regardless of the mitral or aortic
annulus)
 severe aortic or mitral insufﬁciency
 large vegetations
 severe dysfunction of the prosthetic valve.
Then taking under consideration all that and all what
Guidelines had to offer decision about immediate surgery with
an attempt to remove all the visible infection sites, even though
we knew it was an enormously high risk patient, seemed the
only reasonable option. The incidence of surgical treatment of
infective endocarditis has recently increased signiﬁcantly, since
the rate of surgical treatment for multiple valve involvement isalmost 70% [1,3]. Many authors have reported on the surgical
outcomes of multiple valve infective endocarditis [4,5]. Mueller
et al. [4] reported in 25 consecutive patients who underwent
surgery for infective endocarditis (mean follow-up 4.7 years)
28% valve-related complications: ﬁve bleedings (one died), one
embolic event and one prosthetic valve thrombosis. Mihaljevic
et al. [5] showed in 63 patients who underwent multi-valve
surgical procedures for infective endocarditis early mortality of
16%. Out of 53 patients discharged from the hospital 87  4%
were alive at 5 years and 64  9% at 10 years. Musci et al.
described 255 patients who received Shelhigh bioprosthesis
between 2000 and 2007, 74.1% had native and 25.9% had
prosthetic acute infective endocarditis. There was a highly
signiﬁcant difference in survival rate between patients who
were operated on urgently versus in an emergency
(p < 0.0001), between single and double valve replacement
(p = 0.0206) and between patients with and without abscess
formation (p = 0.0245) [6]. Prosthetic valve endocarditis differs
from native valve endocarditis and it has a more difﬁcult
diagnosis and surgical strategy, frequently worse prognosis
[7]. And apparently, even though we used all the current
knowledge, made balanced and well thought decisions,
coming across a very high risk patient with almost all the
complications mentioned in the literature in a single person,
the disease was smarter and the result was fatal.
Conclusions
Infective endocarditis is usually considered as a multifaceted
problem, from etiology and presentation to diagnosis and
management. It is pretty well researched and doctors are well
armed with all different diagnostic and treatment methods.
Despite all that, we still have a lot to learn and a lot to research
when it comes to especially early detection, possibly with
different imaging modalities.
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